Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is receiving European Commission and French government funds to develop vaccines that prote… https://t.co/Ijt0cLCBd0
    about 8 hours ago
  • New post on Science and Enterprise: EC, France Fund Universal Covid-19, Flu Vaccines https://t.co/qT6cmb5P1S #Science #Business
    about 8 hours ago
  • Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a dis… https://t.co/S4C9V2nW0p
    about 14 hours ago
  • New post on Science and Enterprise: Univ. Lab Discovers, Licenses Citrus Disease Treatment https://t.co/Hz2YkVgnac #Science #Business
    about 14 hours ago
  • The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines… https://t.co/7P1yBG9iO5
    about 1 day ago

Please share Science & Enterprise

Trial Indicates App Helps Treat Behavior Disorder

Man with smartphone

Results of a clinical trial suggest a smartphone app designed for use in a therapy program helps some people control their obsessive-compulsive disorder. . . . → Read More: Trial Indicates App Helps Treat Behavior Disorder

Depression Therapy Licensed for Online Distribution

Man with depression

A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital mental health company for online use. . . . → Read More: Depression Therapy Licensed for Online Distribution

Energy Employees Not Ready for Office Return

Engineers at a desk

A survey shows a large majority of energy industry workers prefers to continue working remotely than return their regular offices during the Covid-19 pandemic. . . . → Read More: Energy Employees Not Ready for Office Return

Survey Tracking Covid-19 Mental Health Impact

Mental health scrabble

A survey is underway in the U.S. to gauge the mental health impact of the Covid-19 pandemic, with data also collected with personal activity trackers. . . . → Read More: Survey Tracking Covid-19 Mental Health Impact

Psychiatric Drug Maker Raises $80M in Venture Funds

Psilocybe aztecorum

A developer of treatments for mental health disorders based on controlled hallucinogenic substances is raising $80 million in new venture financing. . . . → Read More: Psychiatric Drug Maker Raises $80M in Venture Funds

Prescription Insomnia App Okayed by FDA

Insomnia

A mobile app prescribed by physicians to treat chronic insomnia is cleared by the Food and Drug Administration for marketing in the U.S. . . . → Read More: Prescription Insomnia App Okayed by FDA

Epilepsy Stimulation Device Detects Other Brain Disorders

Brain activity graphic

An implanted device that stimulates areas of the brain associated with seizures can detect other neurological diseases in people with epilepsy. . . . → Read More: Epilepsy Stimulation Device Detects Other Brain Disorders

Small Biz Grant Funds PTSD Diagnostic, Treatment

Road-side bomb

A company creating diagnostics and a treatment for post-traumatic stress disorder, or PTSD, is receiving initial funding to develop its products. . . . → Read More: Small Biz Grant Funds PTSD Diagnostic, Treatment

Supermarkets to Offer Genetic Mental Health Test

Acme Market

A chain of supermarket pharmacies in Pennsylvania will begin offering genetic tests to help customers manage their mental health medications. . . . → Read More: Supermarkets to Offer Genetic Mental Health Test

Psychedelic Depression Drug Tested for Safety

Psilocybe aztecorum

Results from an early clinical trial testing an hallucinogenic drug to treat depression shows the therapy is largely safe and feasible to administer. . . . → Read More: Psychedelic Depression Drug Tested for Safety